New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 16, 2014
08:07 EDTTROVTrovagene announces clinical collaboratoin with Dana-Farber Cancer Institute
Trovagene announced that it has entered into a clinical collaboration with Dana-Farber Cancer Institute to investigate the utility of quantitative urine-based mutation detection and the ability to monitor tumor mutation burden and treatment response over time in metastatic melanoma patients. Under the agreement, urine samples will be collected from patients with locally advanced or metastatic melanoma known to harbor driver oncogene mutations.
News For TROV From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 20, 2014
09:19 EDTTROVTrovagene's cancer monitoring technology shows detection ability
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use